• LawNY
    $AMRN Amarin gets FDA exclusivity until July 26, 2015 for Vascepa - is that good or bad?
    2/21/14
    Reply (1)
    • invest guru: It doesn't matter, FDA and market HATE AMRN.
      2/24/14